Skip to content

Cognitive Stimulation

Effects of Cognitive Training in Methadone Maintenance Patients

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01271413
Enrollment
134
Registered
2011-01-06
Start date
2010-12-31
Completion date
2013-07-31
Last updated
2014-04-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Substance Use Disorders

Brief summary

This research is being done to learn if computer tasks that challenge the brain (cognitively stimulating tasks) can improve memory and other types of thinking. The study will compare the effects of different versions of the computer tasks. It also will compare the task performance of different groups of people.

Interventions

BEHAVIORALComputerized cognitively stimulating activities

The study will compare the effects of different methods of computerized mental stimulation. The intervention involves 25 sessions involving computerized cognitive tasks.

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
Johns Hopkins University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

* age 18-55 * in methadone maintenance or healthy volunteers * healthy

Exclusion criteria

* Axis I disorder (except substance abuse and dependence in methadone maintenance patients) * severe cognitive impairment * serious untreated medical condition

Design outcomes

Primary

MeasureTime frameDescription
Working Memorybaseline, 7 weeksChange in maximum number of digits correctly recalled in Digit Span Backwards task, from baseline to 7 weeks

Secondary

MeasureTime frame
Episodic Memorybaseline, 7 weeks
Trail-makingbaseline, 7 weeks
go/No-gobaseline, 7 weeks
Delay Discountingbaseline, 7 weeks
Digit Symbol Substitution Testbaseline, 7 weeks
Addiction Severity Indexbaseline, 7 weeks

Countries

United States

Participant flow

Participants by arm

ArmCount
Cognitively Stimulating Activities
Computerized cognitively stimulating activities: The study will compare the effects of different methods of computerized mental stimulation. The intervention involves 25 sessions involving computerized cognitive tasks.
28
Cognitively Stimulating Activities: Other
Computerized cognitively stimulating activities: The study will compare the effects of different methods of computerized mental stimulation. The intervention involves 25 sessions involving computerized cognitive tasks.
28
Total56

Baseline characteristics

CharacteristicCognitively Stimulating ActivitiesCognitively Stimulating Activities: OtherTotal
Age, Continuous43.3 years
STANDARD_DEVIATION 8.8
43.5 years
STANDARD_DEVIATION 7.1
43.4 years
STANDARD_DEVIATION 7.9
Region of Enrollment
United States
28 participants28 participants56 participants
Sex: Female, Male
Female
14 Participants16 Participants30 Participants
Sex: Female, Male
Male
14 Participants12 Participants26 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 370 / 36
serious
Total, serious adverse events
0 / 370 / 36

Outcome results

Primary

Working Memory

Change in maximum number of digits correctly recalled in Digit Span Backwards task, from baseline to 7 weeks

Time frame: baseline, 7 weeks

ArmMeasureValue (MEAN)Dispersion
Adaptive Cognitively Stimulating ActivitiesWorking Memory0.86 digits recalledStandard Deviation 1.21
Non-adaptive Cognitively Stimulating ActivitiesWorking Memory0.04 digits recalledStandard Deviation 0.92
Secondary

Addiction Severity Index

Time frame: baseline, 7 weeks

Secondary

Delay Discounting

Time frame: baseline, 7 weeks

Secondary

Digit Symbol Substitution Test

Time frame: baseline, 7 weeks

Secondary

Episodic Memory

Time frame: baseline, 7 weeks

Secondary

go/No-go

Time frame: baseline, 7 weeks

Secondary

Trail-making

Time frame: baseline, 7 weeks

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026